I don't know how to treat amyloidosis

Morie A. Gertz

doi:10.1182/blood-2010-04-279901

I don't know how to treat amyloidosis

Morie A. Gertz

Hematology

Research output: Contribution to journal › Comment/debate › peer-review

23 Scopus citations

Abstract

In this issue of Blood, Dietrich and colleagues report disappointing results with the use of melphalan parenterally with dexamethasone in patients with immunoglobulin light chain amyloidosis. The median survival of 61 patients was 17.5 months. The 3 months all cause mortality was 28%.

Original language	English (US)
Pages (from-to)	507-508
Number of pages	2
Journal	Blood
Volume	116
Issue number	4
DOIs	https://doi.org/10.1182/blood-2010-04-279901
State	Published - Jul 29 2010

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2010-04-279901

Cite this

@article{1f45e2033c36448481ed3e301c61ae32,

title = "I don't know how to treat amyloidosis",

abstract = "In this issue of Blood, Dietrich and colleagues report disappointing results with the use of melphalan parenterally with dexamethasone in patients with immunoglobulin light chain amyloidosis. The median survival of 61 patients was 17.5 months. The 3 months all cause mortality was 28%.",

author = "Gertz, {Morie A.}",

year = "2010",

month = jul,

day = "29",

doi = "10.1182/blood-2010-04-279901",

language = "English (US)",

volume = "116",

pages = "507--508",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "4",

}

TY - JOUR

T1 - I don't know how to treat amyloidosis

AU - Gertz, Morie A.

PY - 2010/7/29

Y1 - 2010/7/29

N2 - In this issue of Blood, Dietrich and colleagues report disappointing results with the use of melphalan parenterally with dexamethasone in patients with immunoglobulin light chain amyloidosis. The median survival of 61 patients was 17.5 months. The 3 months all cause mortality was 28%.

AB - In this issue of Blood, Dietrich and colleagues report disappointing results with the use of melphalan parenterally with dexamethasone in patients with immunoglobulin light chain amyloidosis. The median survival of 61 patients was 17.5 months. The 3 months all cause mortality was 28%.

UR - http://www.scopus.com/inward/record.url?scp=77956534627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956534627&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-04-279901

DO - 10.1182/blood-2010-04-279901

M3 - Comment/debate

C2 - 20671130

AN - SCOPUS:77956534627

SN - 0006-4971

VL - 116

SP - 507

EP - 508

JO - Blood

JF - Blood

IS - 4

ER -

I don't know how to treat amyloidosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this